RecruitingNCT06526468

Chinese PE Multimodality Imaging Artificial Intelligence Study

CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study


Sponsor

China-Japan Friendship Hospital

Enrollment

1,500 participants

Start Date

Sep 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.


Eligibility

Min Age: 14 Years

Inclusion Criteria2

  • Years and older
  • Patients suspected of PE

Exclusion Criteria4

  • Pregnant women
  • Refuse to follow up
  • Incomplete or discontinued imaging scans
  • Insufficient quality of image data to allow for analysis

Interventions

DEVICEArtificial Intelligence

AI technology will provide novel imaging markers and generate a radiology report with relevant key slice imaging and evaluation results


Locations(1)

China-Japan Frendship hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06526468


Related Trials